http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
xiii, 675 pages : illustrations ; 29 cm.
Pt. 1. Introduction -- The immune system 3 -- Endothelial cells in immune inflammation --Pt. 2. Drugs -- Antimetabolites and radiomimetics -- Cyclophosphamide -- The purine antagonists: azathioprine and mycophenolate mofetif -- Methotrexate -- Progress in therapeutic immunosuppression: cyclosporine, tacrolimus(FK506), and rapamycin -- Corticosteroids -- Glucocorticoid hormone action -- Immunosuppressive and anti-inflammatory actions of corticosteroids -- Anti-inflammatory agents -- Cyclo-oxygenase inhibitors -- receptor site blockers -- 5-lipoxygenase inhibitors --Phosphodiesterase inhibitors -- Sulfasalazine and 5-aminosalicylic acid.
Histamine, antihistamines, and the immune response -- Drug theray for AIDS -- Drug therapy for acquired immunodeficiency syndrome -- Pt. 3. Biologic agents -- Cytokines -- Hematopoietic growth factors -- Cytokines that regulate immune inflammation: interleukin-4, -10, and -12 -- The interferons: basic biology and therapeutic potential -- Interleukin-2 immunotherapy -- Interleukin-1 receptor antagonist -- Macromolecules -- Intravenous immunoglobulin therapy -- Immunoglobulin A.
The use of recombinant, soluble forms of the membrane complement C3 receptors, CR1 and CR2, as inhibitors of serum complement activation and function -- Treatment of angioedema resulting from C1 inhibitor deficiency -- Antibody-based therapy -- Production and manipulation of antibodies and T-cell receptors using recombinant DNA technology -- Clinical applications of antileukocyte adhesion molecule monoclonal antibodies -- Antibody therapies of drug overdose -- Anti-idiotype-based therapies -- Immunotherapy of allergic disease -- Chimeric proteins -- Immunotoxins.
Cytokine toxin fusion proteins -- Immunoligands: CTLA41g and the CD28 -t-cell costimulatory pathway -- Vaccines and peptide therapy -- Bacterial vaccines -- Oral administration of antigens -- Vaccine therapies for acquired immunodeficiency syndrome -- Pt. 4. Maneuvers -- Transplantation -- Therapeutic approach to organ transplantation -- Renal Transplantation -- Pancreas transplantation -- Cardiac transplantation: recipient selection and management -- Lung transplanation -- Bone marrow and hemopoietic stem cell transplanation -- Cell transplantation -- Liver transplantation --Xenotransplantation.
Cellular therapy -- Stem cell therapy -- Cytokine gene-transduced tumor vaccines -- Gene therapy -- Gene therapy for inherited immunodeficiencies -- Adjuvant therapy -- Adjuvants -- Extracorporeal therapy -- Extracorporeal photochemotherapy: Cellular therapy for cutaneous T-cell lymphoma, selected autoimmune disorders, and organ transplant rejection -- Additional inverventions -- Tolerogenic peptides -- Plasmapheresis and immunoadsorption.
Includes bibliographical references and index.